Advanced search
Publication Cover
Cancer Biology & Therapy Volume 19, 2018 - Issue 3
Submit an article Journal homepage
1,074
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis

A. Ilhan-MutluDepartment of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, Austria
,
H. TaghizadehDepartment of Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
,
A. BeerDepartment of Pathology, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, Austria
,
W. DolakDepartment of Medicine III, Clinical Division of Gastroenterology, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, Austria
,
A. Ba-SsalamahDepartment of Radiology, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, Austria
,
S. F. SchoppmannDepartment of Surgery, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, Austria
,
M. HejnaDepartment of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, Austria
,
P. BirnerDepartment of Pathology, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, Austria
&
M. PreusserDepartment of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center Vienna, Upper-GI Tumors Unit, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
 show all
Pages 169-174 | Received 05 Jul 2017, Accepted 05 Dec 2017, Published online: 17 Jan 2018

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Atakan Topcu, Muhammed Mustafa Atci, Saban Secmeler, Mehmet Besiroglu, Murat Ayhan, Metin Ozkan, Oktay Bozkurt, Zuhat Urakci, Seval Ay, Caglayan Geredeli, Ayse Irem Yasin & Haci Mehmet Turk. (2021) Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer. Future Oncology 17:31, pages 4157-4169.
Read now

Articles from other publishers (13)

Isabel Porth, Daniela Hirsch, Yonca Ceribas, Philip Weidner, Wilko Weichert, Thorsten Oliver Götze, Sven Perner, Kim Luley, Christian Moritz Heyer, Carolina de la Torre, Ralf-Dieter Hofheinz, Sylvie Lorenzen & Timo Gaiser. (2023) Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. European Journal of Cancer 183, pages 119-130.
Crossref
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Süleyman Şahin, Teoman Şakalar, Cihan Erol, Mehmet Ali Nahit Şendur, Ahmet Bilgehan Şahin, Erdem Çubukçu, Deniz Can Güven, Saadettin Kılıçkap, Yakup Ergün, Doğan Uncu, Nazım Serdar Turhal, Necdet Üskent, Havva Yeşil Çınkır, Atakan Demir, Ramazan Acar, Nuri Karadurmuş, Sema Türker, Mustafa Altınbaş, Mert Karaoğlan & Filiz Çay Şenler. (2021) Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group. Journal of Gastrointestinal Cancer 53:2, pages 282-288.
Crossref
Nian-Long Meng, Yang-kun Wang, Hai-Li Wang, Jun-Ling Zhou & Su-nan Wang. (2022) Research on the Histological Features and Pathological Types of Gastric Adenocarcinoma With Mucinous Differentiation. Frontiers in Medicine 9.
Crossref
Iago Dillion Lima CavalcantiIago Dillion Lima Cavalcanti. 2022. Chemotherapy Protocols and Infusion Sequence. Chemotherapy Protocols and Infusion Sequence 125 200 .
Tae-Hwan Kim, Hun Do Cho, Yong Won Choi, Hyun Woo Lee, Seok Yun Kang, Geum Sook Jeong, Jin-Hyuk Choi, Mi Sun Ahn & Seung-Soo Sheen. (2021) Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data. BMC Cancer 21:1.
Crossref
Fanming Kong, Yang Yao, Renfen Deng, Xiaojiang Li & Yingjie Jia. (2021) Hopes and failures in front-line advanced HER2-positive gastric cancer therapy. Anti-Cancer Drugs 32:7, pages 675-680.
Crossref
Naziha Mansuri, Eva-Maria Birkman, Vanina D. Heuser, Minnamaija Lintunen, Annika Ålgars, Jari Sundström, Raija Ristamäki, Laura Lehtinen & Olli Carpén. (2020) Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome. Virchows Archiv 478:4, pages 707-717.
Crossref
Hannah Christina Puhr & Aysegül Ilhan-Mutlu. (2020) A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature. memo - Magazine of European Medical Oncology 13:4, pages 453-458.
Crossref
Tian Yun, Sunan Wang, Bo Jiang, Changsong Wang, Nianlong Meng, Xutao Yuan & Yangkun Wang. (2020) Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer. Journal of Oncology 2020, pages 1-7.
Crossref
Andrea Beer, Hossein Taghizadeh, Ana-Iris Schiefer, Hannah C. Puhr, Alexander K. Karner, Gerd Jomrich, Sebastian F. Schoppmann, Renate Kain, Matthias Preusser & Aysegül Ilhan-Mutlu. (2020) PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study. Pathology & Oncology Research 26:4, pages 2225-2235.
Crossref
Hannah Christina Puhr, Eleonore Pablik, Anna Sophie Berghoff, Gerd Jomrich, Sebastian Friedrich Schoppmann, Matthias Preusser & Aysegül Ilhan-Mutlu. (2020) Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome. ESMO Open 5:2, pages e000623.
Crossref
Michelle D. Hackshaw, Christine L. Bui, Amy Ladner, Nora Tu, Zahidul Islam, Mary E. Ritchey & Maribel Salas. (2020) Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer. Cancer Treatment and Research Communications 24, pages 100189.
Crossref
. (2018) Trastuzumab. Reactions Weekly 1690:1, pages 183-183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.